Seasonal variations for newly prescribed urate-lowering drugs for asymptomatic hyperuricemia and gout in Japan
Background: Urate-lowering drugs (ULDs) have been approved for treatment of asymptomatic hyperuricemia and gout in Japan. Although serum urate levels and rates of gout onset are known to have seasonal variations, no survey results regarding the seasonality of ULD prescriptions for asymptomatic hyper...
Saved in:
Main Authors: | Masafumi Kurajoh (Author), Seigo Akari (Author), Takashi Nakamura (Author), Yasutaka Ihara (Author), Takumi Imai (Author), Tomoaki Morioka (Author), Masanori Emoto (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database
by: Masataka Honda, et al.
Published: (2021) -
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
by: Davide Viggiano, et al.
Published: (2018) -
NLRP3 Inflammasome - a new universal target of asymptomatic hyperuricemia and gout management
by: P. A. Lebedev, et al.
Published: (2024) -
Effect of Urate-Lowering Therapy on the Progression of Kidney Function in Patients With Asymptomatic Hyperuricemia: A Systematic Review and Meta-Analysis
by: Lin Zhang, et al.
Published: (2022) -
Multifaceted Nutritional Disorders in Elderly Patients Undergoing Dialysis
by: Katsuhito Mori, et al.
Published: (2022)